# Harrow Health Harrow Health is a Public Company based in Nashville, United States. ## Overview - **Organization type:** Public Company - **Headquarters:** Nashville, United States - **Region:** North America - **Address:** Nashville, TN, United States - **Founded:** 2010 - **Assets under management:** Undisclosed - **Website:** harrow.com ## Regulatory record - **Reports private funds:** No ## About Harrow Health is a healthcare company founded in 2012 in Nashville, Tennessee. It specializes in ophthalmic pharmaceuticals, offering ophthalmic medications, compounding services, and branded therapies. ## Sectors - Healthcare Services ## People - Mark L. Baum — CEO - Andrew R. Boll — CFO ## Questions ### Who runs investment decisions at Harrow Health? CEO Mark Baum leads executive decisions, including acquisition strategy for Harrow Health. The board of directors provides oversight. The company's capital allocation is disclosed in its quarterly earnings reports and SEC filings. ### Does Harrow Health own pharmaceutical products or is it a development-stage company? Harrow owns a portfolio of FDA-approved ophthalmic products and commercializes them through a direct sales force. It has multiple approved drugs on the market, including products for dry eye and glaucoma treatment. ### How is Harrow Health structured legally? Harrow Health is a publicly traded corporation listed on NASDAQ under the ticker HROW. It files regular financial reports with the SEC, including 10-K and 10-Q documents. ### Where does Harrow Health generate revenue? The company generates revenue primarily from product sales of its ophthalmic drugs. Its sales force targets eye care professionals in the US. Revenue is reported in its annual filings. ## Related profiles - [eMDs](https://altss.com/profile/emds) - [ZephyrTel](https://altss.com/profile/zephyrtel) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/harrow-health Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology